Participants 217 324 3
total coronary occlusions (Primary Stenting of Totally Occluded Native Coronary Arteries [PRISON] II study)
Participants 410 505 6
patients enrolled in the Primary Stenting of Totally Occluded Native Coronary Arteries II study
Participants 515 793 11
Patients with totally occluded coronary arteries randomized to either sirolimus-eluting Cypher stents (SESs) (Cordis, a Johnson & Joshson Company, Miami Lakes, FL) (100 patients) or bare-metal BxVelocity stents (BMSs) (Cordis) (100 patients) were followed clinically for 3 years
